Effect of vitamin D supplementation on hormones and menstrual cycle regularization in polycystic ovary syndrome women: A systemic review and meta‐analysis

Author:

Han Yixian123ORCID,Cao Qi123ORCID,Qiao Xinyu123,Huang Wei123ORCID

Affiliation:

1. Department of Obstetrics and Gynecology West China Second University Hospital of Sichuan University Chengdu People's Republic of China

2. Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education West China Second University Hospital of Sichuan University Chengdu People's Republic of China

3. NHC Key Laboratory of Chronobiology (Sichuan University) Chengdu People's Republic of China

Abstract

AbstractAimPolycystic ovary syndrome (PCOS) is a prevalent endocrine disease among women of childbearing age. Women with PCOS frequently experience reproductive complications, which are closely associated with the concentration of vitamin D. This systemic review and meta‐analysis were conducted to elucidate the possible effect of vitamin D supplementation in PCOS women on hormones, including Luteinizing hormone (LH), follicle‐stimulating hormone (FSH), the ratio of LH and FSH (LH/FSH), and the menstrual cycle regularization.MethodsWe searched PubMed, Web of Science, Ovid MEDLINE, Cochrane Library, and EMBASE for the relevant articles published up to January 2022. The pooled estimates were calculated using RevMan 5.4 software.ResultsTwelve studies involving 849 PCOS patients were included. Our study indicated that vitamin D supplementation could reduce serum LH (standard mean difference [SMD]: −0.41; 95% confidence interval [CI]: −0.54, −0.28; p < 0.01). Subgroup analysis identified that the supplementation of vitamin D ≤4000 IU/day (SMD: −0.69; 95% CI: −1.15, −0.23; p < 0.01), treatment time ≤8 weeks (SMD: −0.61; 95% CI: −0.95, −0.26; p < 0.01), and vitamin D co‐supplementation (SMD: −0.37; 95% CI: −0.65, −0.10; p < 0.01) were related to reduce serum LH level. In addition, vitamin D supplementation improved the regularity of menstrual cycle significantly (risk ratio [RR]: 1.35; 95% CI: 1.18, 1.54; p < 0.01). In stratified analysis, the significant effects only existed in dosage of vitamin D >4000 IU (RR: 1.62; 95% CI: 1.02, 2.57; p < 0.01), treatment time >8 weeks (RR: 1.41; 95% CI: 1.06, 1.87; p = 0.02) and vitamin D co‐supplementation (RR: 1.18; 95% CI: 1.03, 1.35; p = 0.02). However, vitamin D might have no effects on serum FSH (SMD: −0.05; 95% CI: −0.42, 0.32; p = 0.79) and LH/FSH (SMD: −0.24; 95% CI: −0.55, 0.08; p = 0.14) in PCOS patients.ConclusionsEvidence from the existing randomized controlled trials indicated that vitamin D supplementation might improve the LH level and the menstrual cycle regularization but did not have any effect on FSH and LH/FSH levels in PCOS patients.

Publisher

Wiley

Subject

Obstetrics and Gynecology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Role of the NLRP3 inflammasome in gynecological disease;Biomedicine & Pharmacotherapy;2023-10

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3